Skip to main content
Clinical Trials/NCT03822962
NCT03822962
Terminated
Early Phase 1

Post-operative Pain Management Following Functional Endoscopic Sinus Surgery

University of Nebraska2 sites in 1 country10 target enrollmentNovember 7, 2020

Overview

Phase
Early Phase 1
Intervention
Standard Regimen | Tylenol
Conditions
Nasal Sinus; Inflammation
Sponsor
University of Nebraska
Enrollment
10
Locations
2
Primary Endpoint
Pain level
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

This Study evaluates the effect of adding Non-steroidal anti-inflammatories (NSAIDs) to the post-operative pain management of sinus surgery patients and wether or not this addition reduces or eliminates the need for narcotic pain medications.

Patients will be instructed to take an NSAID regimen after surgery and will be instructed to take narcotics only for breakthrough pain.

Detailed Description

National attention has been given to the concerning rise of opioid abuse in this country, with prescriptions for this medications more than quadrupaling in the last 17 years. Little is known as to the appropriate use of opioid analgesics in the post-operative recovery of patients undergoing sinus surgery. Furthermore, most pain protocols include only Tylenol based opioid analgesics. No study has prospectively evaluated the volume of use of Tylenol based opioid analgesics and whether the addition of NSAIDS decreased the need for opioid analgesics. This study will compare opioid use with and without the addition of NSAIDS following sinus surgery. Post-operative opioid use is a great public health concern, relatively unstudied, and an area with an opportunity for potential intervention to significantly reduce risks, morbidity, and mortality to our postoperative patients by better formulating a postoperative pain management plan using evidence-based practices. Appropriate opioid prescribing practices can reduce the risk of addiction, drug overdose, death, and undertreated pain. By optimizing post-operative pain management protocols, the need for opioids following sinus surgery should be minimized.

Registry
clinicaltrials.gov
Start Date
November 7, 2020
End Date
May 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients age 18-65 undergoing functional endoscopic sinus surgery +/- nasal airway surgery (septoplasty and/or inferior turbinate reduction).

Exclusion Criteria

  • Not taking anti-coagulation medications including aspirin
  • Clinical Diagnosis of aspirin-exacerbated respiratory disease
  • Clinical Diagnosis of Cystic Fibrosis
  • Clinical Diagnosis of Primary Ciliary Dyskinesia
  • Inclusion of a Draf III frontal sinusotomy
  • Clinical Diagnosis of Liver/Kidney Failure
  • Clinical Diagnosis of Thrombocytopenia
  • Clinical Diagnosis of Poorly controlled hypertension
  • Clinical Diagnosis of Recent GI ulcers or gastritis
  • Clinical Diagnosis of Chronic pain as defined by a narcotic prescription with 6 months or involvement in a pain management program

Arms & Interventions

Standard Tylenol Regimen

Patient will be given a standard regimen: Tylenol 1000 mg by mouth every 6 hours scheduled and a rescue prescription of oxycodone 5 mg tablets by mouth every 6 hours as needed for pain. Ten total oxycodone tablets will be prescribed.

Intervention: Standard Regimen | Tylenol

Ibuprofen 600mg

Tylenol 1000 mg by mouth every 6 hours scheduled and ibuprofen 600 mg tablet by mouth every 8 hours scheduled and a rescue prescription of oxycodone 5 mg tablets by mouth every 6 hours as needed for pain. Ten total oxycodone tablets will be prescribed.

Intervention: Ibuprofen 600Mg Tablet

Ibuprofen 600mg

Tylenol 1000 mg by mouth every 6 hours scheduled and ibuprofen 600 mg tablet by mouth every 8 hours scheduled and a rescue prescription of oxycodone 5 mg tablets by mouth every 6 hours as needed for pain. Ten total oxycodone tablets will be prescribed.

Intervention: Standard Regimen | Tylenol

Outcomes

Primary Outcomes

Pain level

Time Frame: 1 week

Patients will be given a Visual Analogue scale to help document their level of pain from Post-operative days 0, 1, 2, 3, 4 ,5 and the first post-operative visit with the surgeon. The patient will measure their pain score each time they take medication. The pain scale called the Wong-Baker FACES pain rating scale is a 0-10 pain scale. 0 = no hurt, 2 = hurts little bit, 4 = hurts little more, 6 = hurts even more, 8 = hurts whole lot, 10 = hurts worst. The numbers are added up to a sum and put into their perspective category known by the Otolaryngologist.

Secondary Outcomes

  • Rate of bleeding(1 week)

Study Sites (2)

Loading locations...

Similar Trials